A Phase II Study of continuous, low-dose LBH 589 (Panobinostat) in Patients with Refractory Solid Tumors, including CNS tumors

  • Desai, Jayesh (Primary Chief Investigator (PCI))
  • Ashley, David M. (Chief Investigator (CI))
  • Cain, Jason (Chief Investigator (CI))
  • Gottardo, Nicholas G (Chief Investigator (CI))
  • Wood, Paul, (Chief Investigator (CI))
  • Strong, Robyn, (Project Manager)

Project: Research

StatusActive
Effective start/end date1/07/1731/12/21

Funding

  • The Kids' Cancer Project: AUD61,420.00
  • National Health & Medical Research Council (NHMRC): AUD811,512.00